MTNBMatinas BioPharma Holdings, Inc.

CSNYSE American, LLC (XASE)·USD

Identity

Security key: 18856
Ticker: MTNB
Type: CS — Common Stock
Exchange: NYSE American, LLC(XASE)
Venue group: NYSE
Operating MIC: XNYS
Market: stocks
Locale: us
Currency: USD
Listed: 2014-07-21
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: MTNB

Detail

Enriched 2026-08-14 20:47

Market cap: $1,537,485.84
Shares outstanding (class): 13,692,796
Shares outstanding (weighted): 6,406,191
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 2
Location: BEDMINSTER, NJ
Homepage: https://www.matinasbiopharma.com
Description: Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.

Market cap and share counts drift.

Funds holding this security

1 funds · 1 positions · $20.1K reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$20.1K	0.00%	40,110 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERMTNB
FIGI_COMPOSITEBBG005WX2XG8
FIGI_SHARE_CLASSBBG005WX2XH7
CIK0001582554
ISINUS5768103039
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: The company is a biopharmaceutical firm focused on developing therapies, matching the pharmaceutical preparations SIC code.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.